721
Participants
Start Date
January 31, 2006
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
everolimus
Everolimus supplied as 0.75 mg tablets. Everolimus was also supplied in 0.25 mg and 0.5 mg tablets for dose adjustments.
mycophenolate mofetil
Mycophenolate mofetil supplied as 500 mg tablets.
cyclosporine
Cyclosporine reduced dose in the everolimus arms (approximately half of the standard dose) and standard dose in the mycophenolate mofetil arm.
corticosteroids
Corticosteroids standard dose.
University of Wisconsin - Madison Medical School, Madison
Methodist Hospital/DeBakey Heart Failure Research Center, Houston
UCLA Medical Center, Los Angeles
California Pacific Medical Center, San Francisco
Stanford U Sch, Falk Cardiovasular Research Ctr., Stanford
University of Florida Shands Hospital, Gainesville
Emory University Hospital, Atlanta
Loyola Univerisity Medical School, Maywood
Massachusetts General Hospital, Boston
Tufts Medical Center, Boston
University of Michigan Health System, Ann Arbor
Washington University School of Medicine, St Louis
Columbia University Medical Center, New York
Recanati Miller Transplant Institute, New York
UNC Division of Cardiology, Chapel Hill
Duke University Heart Failure Research, Durham
Cleveland Clinic Foundation, Cleveland
Penn State College of Medicine, Hershey
Hahnemann University Hospital, Philadelphia
Temple University Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Medical University of South Carolina, Charleston
Texas Cardiovascular Consultants, Austin
University of Texas Medical Branch, Div of Cardio Thoracic, Galveston
Intermountain Medical Center, Murray
St. Luke's Medical Center Cardiac Services, Milwakee
Sanatorio Parque, Rosario
Fundacion Favalaro, Buenos Aires
St Vincents Hospital, Darlinghurst
Prince Charles Hospital, Chermside
Royal Perth Hospital, Perth
Universitaet Wien, Vienna
Cliniques Universitaires Saint-Luc, Brussels
University of Alberta Hospital, Edmonton
St Paul's Hospital, Vancouver
New Halifax Infirmary, Halifax
Toronto General Hospital, Toronto
Institut Univ. de cardiologie et pneumologie de Quebec, Sainte-Foy
Hopital Cardiologique de Lyon, Lyon
Hopital Georges Pompidou, Paris
Hopital Pitie Salpetriere, Paris
CHU de Strasbourg Hopital Civil Medicale B, Strasbourg
CHU Hopital de Brabois, Vandœuvre-lès-Nancy
Herz- u. Diabeteszentrum NRW/Ruhr-Univ. Bochum, Bad Oeynhausen
Deutsches Herzzentrum Berlin, Berlin
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Kliniken der Med. Hochschule, Hanover
Universitaetsklinikum Kiel, Kiel
Universitaetsklinik Regensburg, Regensburg
Az. Osp. di Bologna Policl. S. Orsola-Malpighi Univ. degli Studi, Bologna
Azienda Ospedaliera G. Brotzu, Cagliari
A.O.-Universita di Padova-Universita degli Studi, Padua
Fodazione IRCCS Policlinico S. Matteo, Pavia
Azienda Ospedaliera S. Camillo-Forlanini, Roma
Az. Ospedaliero-Universitaria S. Giovanni Battista di Torino, Torino
Auckland Hospital, Auckland
Rikshospitalet, Hjertemedisinskavdeling, Oslo
Cardiovascular Center of Puerto Rico and the Caribbean, San Juan
Hospital Universitario Reina Sofia, Córdoba
Hospital Puerta de Hierro Majadahonda, Madrid
National Taiwan University Hospital, Taipei
Queen Elizabeth Hospital, Birmingham
Papworth Hospital, Cambridge
Wythenshawe Hospital, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY